Advancing Retinal Drug Delivery Through Innovative Injection Technology
Key Challenges
DALI has been developing drug delivery devices from concept to commercialization since 2003, serving pharmaceutical and medical device companies.
Our injectable solutions are designed to improve patient compliance with biologic, biosimilar, and generic therapies, offering greater ease, comfort, and enabling simple self-administration. With expertise across the full product lifecycle, we provide both market-ready devices and customizable solutions tailored to specific needs-covering everything from design and development to verification, validation, and compliance with all relevant standards and regulations.